Skip to content
No picture yet

Alendronate-70 70 mg – DIN 02303078

Alendronate-70 is Alendronate 70 mg (tablet), sold in Canada. It is used for osteoporosis (weak bones). It is supplied by Pro Doc Limitee. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Alendronate 70 mg

Brand
Alendronate-70
Strength
70 mg
Used for
Osteoporosis (weak bones)
Form
Tablet
Manufacturer
Pro Doc Limitee
Drug class
Bone medicine (bisphosphonate)
Sold in
Canada
DIN
02303078

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Alendronate pills and guides

What is Alendronate used for?

Alendronate is used for osteoporosis (weak bones).

Medicine type
Bone medicine (bisphosphonate)
Official uses from the US prescribing label

Treatment of Osteoporosis in Postmenopausal Women

Alendronate sodium tablets, USP are indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, alendronate sodium tablets, USP increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures).

Prevention of Osteoporosis in Postmenopausal Women

Alendronate sodium tablets, USP are indicated for the prevention of postmenopausal osteoporosis.

Treatment to Increase Bone Mass in Men with Osteoporosis

Alendronate sodium tablets, USP are indicated for treatment to increase bone mass in men with osteoporosis.

Treatment of Glucocorticoid-Induced Osteoporosis

Alendronate sodium tablets, USP are indicated for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density.

Treatment of Paget's Disease of Bone

Alendronate sodium tablets, USP are indicated for the treatment of Paget's disease of bone in men and women. Treatment is indicated in patients with Paget's disease of bone who have alkaline phosphatase at least two times the upper limit of normal, or those who are symptomatic, or those at risk for future complications from their disease.

Important Limitations of Use

The optimal duration of use has not been determined. The safety and effectiveness of alendronate sodium for the treatment of osteoporosis are based on clinical data of four years duration. All patients on bisphosphonate therapy should have the need for continued therapy re-evaluated on a periodic basis. Patients at low-risk for fracture should be considered for drug discontinuation after 3 to 5 years of use. Patients who discontinue therapy should have their risk for fracture re-evaluated periodically.

From the FDA-approved label on DailyMed (published Jul 06, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02303078.
  • It names Alendronate-70, Alendronate 70 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Alendronate-70 by Pro Doc Limitee.

In Canada: prescription only.

Ingredients

Active: Alendronic Acid (Alendronate Sodium)

Other Alendronate pills